INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-17-00662

Combined jugular and femoral approach for treating severe tricuspid valve regurgitation

Amnon Eitan, MD; Claudia Tiburtius, MD; Julian Witt, MD; Joachim Schofer*, MD, PhD

In 2013, a 78-year-old lady underwent surgery for reconstruction of her mitral valve with a 30 mm Carpentier-Edwards Physio annuloplasty ring (Edwards Lifesciences, Irvine, CA, USA) and reconstruction of her tricuspid valve with a 32 mm Carpentier-Edwards Physio tricuspid annuloplasty ring (Edwards Lifesciences). Gradually, a severe tricuspid regurgitation developed with heart failure of NYHA Class III.

Current echocardiography demonstrated high-grade tricuspid regurgitation with both a valvular and a large paravalvular (PV) regurgitation (Panel A: arrow - tricuspid ring; double arrow - giant PV space sized 34×36 mm; *mitral ring). Considering the patient’s high risk, the Heart Team decided to attempt a percutaneous intervention.

Through a right femoral vein approach, a 29 mm Edwards SAPIEN 3 valve (Edwards Lifesciences) was introduced and positioned in the tricuspid valve ring. The help of a snare introduced through the contralateral femoral vein was required due to the difficult angle passing from the inferior vena cava (IVC) into the right ventricle (Panel B: arrowhead - SAPIEN 3; double arrow - snare).

For the next stage, we used a 28 mm AMPLATZER® Septal Occluder (St. Jude Medical, St. Paul, MN, USA) for sealing the paravalvular leak. Attempts to position the device through a right femoral vein approach failed; therefore, we switched to a right jugular vein approach to achieve a better angle. With the help of a snare introduced through the femoral vein (Panel C: double arrowhead - Occluder guide; double arrow – snare) (Moving image 1), the Occluder was placed and released in the correct position in the paravalvular space. Follow-up fluoroscopy showed the devices to be well positioned (Panel D: arrow - SAPIEN 3; arrowhead – Occluder; * mitral ring).

Percutaneous procedures of the tricuspid valve are difficult, mainly because of the angle of approach. The use of both the jugular and the femoral approach and the help of a snare may facilitate this procedure.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. Manipulation of the AMPLATZER Occluder delivery sheath introduced from the jugular approach with the help of a snare introduced from the femoral approach.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Manipulation of the AMPLATZER Occluder delivery sheath introduced from the jugular approach with the help of a snare introduced from the femoral approach.

Volume 13 Number 13
Jan 19, 2018
Volume 13 Number 13
View full issue


Key metrics

On the same subject

SPECIAL REPORT

10.4244/EIJV11I13A296 Apr 20, 2016
First transfemoral percutaneous edge-to-edge repair of the tricuspid valve using the MitraClip system
Wengenmayer T et al
free

Image – Interventional flashlight

10.4244/EIJ-D-21-00243 Dec 3, 2021
Iatrogenic interatrial shunt reversal with transcatheter tricuspid valve repair
Tavlaki E et al
free

10.4244/EIJV15I10A159 Nov 15, 2019
The five Ws of transcatheter tricuspid valve repair: Who, What, When, Where, and Why
Williams A et al
free

Image – Interventional flashlight

10.4244/EIJ-D-21-00614 Dec 17, 2021
Transfemoral transcatheter tricuspid valve replacement after failed leaflet repair
Wild M et al
free

EXPERT REVIEW

10.4244/EIJ-D-17-00571 Sep 24, 2017
The big parade: emerging percutaneous mitral and tricuspid valve devices
Natarajan D et al
free

Image – Interventional flashlight

10.4244/EIJ-D-18-00956 Mar 20, 2019
FORMA Tricuspid Repair System: device enhancements and initial experience
Asmarats L et al
free

10.4244/EIJV12SYA28 Sep 18, 2016
Percutaneous interventional options for the treatment of tricuspid regurgitation
Haude M and Prendergast B
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00693 Nov 20, 2017
Transcatheter edge-to-edge repair of lead-associated tricuspid regurgitation
Fam N et al
free
Trending articles
281.88

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved